EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update.

© Europa Digital & Publishing 2020. All rights reserved. *Corresponding author: Shaare Zedek Medical Center, POB 3235, Jerusalem 9103102, Israel. Tel. Administrative office: 972-(0)2-6555975. Fax: 972-(0)2-6555437. E-mail address: mglikson@szmc.org.il This article has been co-published with permission in EP Europace and EuroIntervention. All rights reserved. © 2019 the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions. The articles are identical except for minor stylistic and spelling differences in keeping with each journal’s style. Either citation can be used when citing this article. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update

[1]  S. Iyengar,et al.  Watchman™ Left Atrial Appendage Closure Device , 2020, Practical Handbook of Advanced Interventional Cardiology.

[2]  Randall J. Lee,et al.  Combination of Left Atrial Appendage Isolation and Ligation to Treat Nonresponders of Pulmonary Vein Isolation. , 2018, JACC. Clinical electrophysiology.

[3]  F. Laurent,et al.  Left atrial appendage patency and device-related thrombus after percutaneous left atrial appendage occlusion: a computed tomography study , 2018, European heart journal cardiovascular Imaging.

[4]  Yun Gi Kim,et al.  Electrical isolation of the left atrial appendage increases the risk of ischemic stroke and transient ischemic attack regardless of postisolation flow velocity. , 2018, Heart rhythm.

[5]  G. Lip,et al.  The prothrombotic state in atrial fibrillation: pathophysiological and management implications , 2018, Cardiovascular Research.

[6]  E. Pokushalov,et al.  Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[7]  A. Natale,et al.  Thrombogenic and Arrhythmogenic Roles of the Left Atrial Appendage in Atrial Fibrillation. , 2018, Circulation.

[8]  T. Sundt,et al.  Concomitant surgical closure of left atrial appendage: A systematic review and meta‐analysis , 2018, The Journal of thoracic and cardiovascular surgery.

[9]  K. Chun,et al.  Antithrombotic strategies after interventional left atrial appendage closure: an update , 2018, Expert review of cardiovascular therapy.

[10]  V. Reddy,et al.  Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes , 2018, Circulation.

[11]  J. Camm,et al.  Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[12]  W. O’Neill,et al.  Prospective, randomized comparison of 3‐dimensional computed tomography guidance versus TEE data for left atrial appendage occlusion (PRO3DLAAO) , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[13]  P. Noseworthy,et al.  Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery , 2018, JAMA.

[14]  E. Di Angelantonio,et al.  Is von Willebrand factor associated with stroke and death at mid-term in patients with non-valvular atrial fibrillation? , 2018, Archives of cardiovascular diseases.

[15]  P. Kirchhof,et al.  Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation , 2018, Cardiovascular research.

[16]  Pascal Defaye,et al.  Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation. , 2018, Journal of the American College of Cardiology.

[17]  K. Chun,et al.  Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[18]  I. Cruz-González,et al.  Left Atrial Appendage Occlusion: The Current Device Landscape and Future Perspectives. , 2018, Interventional cardiology clinics.

[19]  M. Price.  The WATCHMAN Left Atrial Appendage Closure Device: Technical Considerations and Procedural Approach. , 2018, Interventional cardiology clinics.

[20]  Charan T. Yerasi,et al.  An updated systematic review and meta‐analysis of early outcomes after left atrial appendage occlusion , 2018, Journal of interventional cardiology.

[21]  J. Saw,et al.  Incidence, Prevention, and Management of Periprocedural Complications of Left Atrial Appendage Occlusion. , 2018, Interventional cardiology clinics.

[22]  G. Lip,et al.  Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction , 2018, Nature Reviews Nephrology.

[23]  M. Hołda,et al.  Left‐Sided Atrial Septal Pouch is a Risk Factor for Cryptogenic Stroke , 2018, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[24]  S. Bangalore,et al.  Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet Therapy , 2018, Circulation. Cardiovascular interventions.

[25]  B. Meier.  What Lies Beneath Left Atrial Appendage Occlusion: Know Your Enemy. , 2018, Circulation. Cardiovascular interventions.

[26]  J. Piccini,et al.  Association Between Left Atrial Appendage Occlusion and Readmission for Thromboembolism Among Patients With Atrial Fibrillation Undergoing Concomitant Cardiac Surgery , 2018, JAMA.

[27]  C. Tondo,et al.  Left atrial appendage closure using AMPLATZER™ devices: A large, multicenter, Italian registry. , 2017, International journal of cardiology.

[28]  Stephen G. Worthley,et al.  CT sizing for left atrial appendage closure is associated with favourable outcomes for procedural safety , 2017, European heart journal cardiovascular Imaging.

[29]  J. Saw.  Intracardiac Echocardiography for Endovascular Left Atrial Appendage Closure: Is it Ready for Primetime? , 2017, JACC. Cardiovascular interventions.

[30]  Saibal Kar,et al.  5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. , 2017, Journal of the American College of Cardiology.

[31]  J. Mandrola,et al.  Percutaneous left atrial appendage closure is not ready for routine clinical use. , 2017, Heart rhythm.

[32]  V. Guetta,et al.  Printed MDCT 3D models for prediction of left atrial appendage (LAA) occluder device size: a feasibility study. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[33]  T. Potpara,et al.  Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[34]  G. Lip,et al.  Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation. , 2017, Journal of the American College of Cardiology.

[35]  B. Schmidt,et al.  Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical/echocardiographic data from a global prospective observational study. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[36]  S. Kische,et al.  Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[37]  S. Kische,et al.  Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial. , 2017, Heart rhythm.

[38]  Deepak L. Bhatt,et al.  Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease , 2017, The New England journal of medicine.

[39]  W. Schillinger,et al.  Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Previous Major Gastrointestinal Bleeding (from the Amplatzer Cardiac Plug Multicenter Registry). , 2017, The American journal of cardiology.

[40]  K. Stein,et al.  Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[41]  J. Saw,et al.  The Assessment of the Watchman Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO) trial. , 2017, American heart journal.

[42]  M. Rosenqvist,et al.  Left atrial appendage occlusion versus standard medical care in patients with atrial fibrillation and intracerebral haemorrhage: a propensity score-matched follow-up study. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[43]  A. Tzikas,et al.  A comparison of two-dimensional and real-time 3D transoesophageal echocardiography and angiography for assessing the left atrial appendage anatomy for sizing a left atrial appendage occlusion system: impact of volume loading. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[44]  J. Saw,et al.  Incidence and Clinical Impact of Device-Associated Thrombus and Peri-Device Leak Following Left Atrial Appendage Closure With the Amplatzer Cardiac Plug. , 2017, JACC. Cardiovascular interventions.

[45]  D. W. Davies,et al.  Percutaneous left atrial appendage occlusion using different technologies in the United Kingdom: A multicenter registry , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[46]  W. O’Neill,et al.  Post-Approval U.S. Experience With Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation. , 2017, Journal of the American College of Cardiology.

[47]  D. Singer,et al.  Wide Variation in Reported Rates of Stroke Across Cohorts of Patients With Atrial Fibrillation , 2017, Circulation.

[48]  Michael Glikson,et al.  Cardiac CT Angiography (CCTA) predicts left atrial appendage occluder device size and procedure outcome , 2017, The International Journal of Cardiovascular Imaging.

[49]  Thomas Song,et al.  Application of 3-Dimensional Computed Tomographic Image Guidance to WATCHMAN Implantation and Impact on Early Operator Learning Curve: Single-Center Experience. , 2016, JACC. Cardiovascular interventions.

[50]  A. Dello Russo,et al.  Concomitant cryoballoon ablation and percutaneous closure of left atrial appendage in patients with atrial fibrillation. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[51]  Dhanunjaya R. Lakkireddy,et al.  Left Atrial Appendage Isolation in Patients With Longstanding Persistent AF Undergoing Catheter Ablation: BELIEF Trial. , 2016, Journal of the American College of Cardiology.

[52]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[53]  G. Lip,et al.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[54]  P. McCarthy,et al.  A randomized, prospective pilot comparison of 3 atrial appendage elimination techniques: Internal ligation, stapled excision, and surgical excision. , 2016, The Journal of thoracic and cardiovascular surgery.

[55]  G. Lip,et al.  Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease. , 2016, Journal of the American College of Cardiology.

[56]  A. Hobbs,et al.  Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial. , 2016, International journal of cardiology.

[57]  L. Pérez de Isla,et al.  Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials , 2016, Heart.

[58]  E. Tuzcu,et al.  Feasibility of LAA Closure for Left Atrial Thrombus in Patients With Aortic Stenosis and AF. , 2016, Journal of the American College of Cardiology.

[59]  R. Bai,et al.  Over 1-year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials and observational studies. , 2016, Heart Rhythm.

[60]  Mita B. Patel,et al.  Impact of Diastolic Function Parameters on the Risk for Left Atrial Appendage Thrombus in Patients with Nonvalvular Atrial Fibrillation: A Prospective Study. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[61]  K. Kuck,et al.  Unexpectedly High Incidence of Stroke and Left Atrial Appendage Thrombus Formation After Electrical Isolation of the Left Atrial Appendage for the Treatment of Atrial Tachyarrhythmias , 2016, Circulation. Arrhythmia and electrophysiology.

[62]  Dhanunjaya R. Lakkireddy,et al.  Short and long-term outcomes of percutaneous left atrial appendage suture ligation: Results from a US multicenter evaluation. , 2016, Heart rhythm.

[63]  Paul L. Hess,et al.  SCAI/ACC/HRS institutional and operator requirements for left atrial appendage occlusion. , 2016, Heart rhythm.

[64]  Sergio Berti,et al.  Left atrial appendage occlusion with the AMPLATZER Amulet device: an expert consensus step-by-step approach. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[65]  Roshan Prakash,et al.  Comparing Measurements of CT Angiography, TEE, and Fluoroscopy of the Left Atrial Appendage for Percutaneous Closure , 2016, Journal of cardiovascular electrophysiology.

[66]  B. Meier,et al.  Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. , 2016, International journal of cardiology.

[67]  B. Meier,et al.  Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[68]  Roger D. White,et al.  Left Atrial Appendage Patency at Cardioversion After Surgical Left Atrial Appendage Intervention. , 2016, The Annals of thoracic surgery.

[69]  S. Kische,et al.  Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry , 2016, European heart journal.

[70]  J. Saw,et al.  Changes in Left Atrial Appendage Dimensions Following Volume Loading During Percutaneous Left Atrial Appendage Closure. , 2015, JACC. Cardiovascular interventions.

[71]  M. Price,et al.  Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience. , 2015, JACC. Cardiovascular interventions.

[72]  A. Mügge,et al.  Initial Experience With Novel Oral Anticoagulants During the First 45 Days After Left Atrial Appendage Closure With the Watchman Device , 2015, Clinical cardiology.

[73]  G. Marcus,et al.  Left Atrial Appendage Ligation in Nonvalvular Atrial Fibrillation Patients at High Risk for Embolic Events With Ineligibility for Oral Anticoagulation: Initial Report of Clinical Outcomes. , 2015, JACC. Clinical electrophysiology.

[74]  P. Mclaughlin,et al.  Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure. , 2015, European heart journal cardiovascular Imaging.

[75]  S. Bertog,et al.  “A bend in time”: Shaping the sheath facilitates left atrial appendage closure , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[76]  H. Calkins,et al.  2015 ACC/HRS/SCAI left atrial appendage occlusion device societal overview. , 2015, Heart rhythm.

[77]  J. Gavira,et al.  Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[78]  Frederick T. Han,et al.  Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: Understanding the differences in the location and type of leaks and their clinical implications. , 2015, Heart rhythm.

[79]  Saibal Kar,et al.  Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis. , 2015, Journal of the American College of Cardiology.

[80]  P. Wenaweser,et al.  Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation , 2015, Clinical Research in Cardiology.

[81]  I. Cruz González,et al.  Two-year clinical outcome from the Iberian registry patients after left atrial appendage closure , 2015, Heart.

[82]  P. Neužil,et al.  Multicenter study on acute and long-term safety and efficacy of percutaneous left atrial appendage closure using an epicardial suture snaring device. , 2014, Heart rhythm.

[83]  F. Mori,et al.  Periprocedural intracardiac echocardiography for left atrial appendage closure: a dual-center experience. , 2014, JACC. Cardiovascular interventions.

[84]  José Ramón López-Mínguez,et al.  Comparison of imaging techniques to assess appendage anatomy and measurements for left atrial appendage closure device selection. , 2014, The Journal of invasive cardiology.

[85]  M. Price,et al.  Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. , 2014, Journal of the American College of Cardiology.

[86]  A. Parkhomenko,et al.  Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials , 2014, The Lancet.

[87]  E. Tuzcu,et al.  Percutaneous left atrial appendage occlusion for stroke prophylaxis in nonvalvular atrial fibrillation: a systematic review and analysis of observational studies. , 2014, JACC. Cardiovascular interventions.

[88]  T. Kawagoe,et al.  Thrombus in the left atrial septal pouch mimicking myxoma , 2014, Journal of clinical ultrasound : JCU.

[89]  Hiroshi Ashikaga,et al.  Relationship between left atrial appendage morphology and stroke in patients with atrial fibrillation. , 2013, Heart rhythm.

[90]  E. Antman,et al.  Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.

[91]  Nassir Marrouche,et al.  Association of Atrial Fibrosis Quantified Using LGE‐MRI with Atrial Appendage Thrombus and Spontaneous Contrast on Transesophageal Echocardiography in Patients with Atrial Fibrillation , 2013, Journal of cardiovascular electrophysiology.

[92]  P. Wenaweser,et al.  Amplatzer left atrial appendage occlusion: Single center 10‐year experience , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[93]  D. Atar,et al.  Mass screening for silent atrial fibrillation in high risk patients - preliminary results from the STROKESTOP trial , 2013 .

[94]  Frederick T. Han,et al.  Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. , 2013, Journal of the American College of Cardiology.

[95]  J. Saw,et al.  Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy. , 2013, Journal of the American College of Cardiology.

[96]  P. Neužil,et al.  Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). , 2013, Journal of the American College of Cardiology.

[97]  C. Bruce,et al.  Novel percutaneous left atrial appendage closure. , 2013, Cardiovascular revascularization medicine : including molecular interventions.

[98]  Mario J. Garcia,et al.  Detection of Left Atrial Appendage Thrombus by Cardiac Computed Tomography in Patients With Atrial Fibrillation: A Meta-Analysis , 2013, Circulation. Cardiovascular imaging.

[99]  P. Neužil,et al.  Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial , 2013, Circulation.

[100]  B. Meier,et al.  Left atrial appendage closure for "primary primary" prevention during percutaneous closure of septal defects in patients with large atria but no atrial fibrillation. , 2013, Cardiology journal.

[101]  V. Falk,et al.  Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage. , 2012, Interactive cardiovascular and thoracic surgery.

[102]  E. Di Angelantonio,et al.  C-reactive protein and transesophageal echocardiographic markers of thromboembolism in patients with atrial fibrillation. , 2012, International journal of cardiology.

[103]  J. Burkhardt,et al.  Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. , 2012, Journal of the American College of Cardiology.

[104]  R. Mahajan,et al.  Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure , 2012, Heart.

[105]  G. Lip,et al.  Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report , 2012, Chest.

[106]  J. Troupis,et al.  Presence of accessory left atrial appendage/diverticula in a population with atrial fibrillation compared with those in sinus rhythm: a retrospective review , 2012, The International Journal of Cardiovascular Imaging.

[107]  B. Pamukcu,et al.  The CD40-CD40L system in cardiovascular disease , 2011, Annals of medicine.

[108]  G. Lip,et al.  Apixaban in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[109]  S. Yakubov,et al.  Feasibility of closed-chest ligation of the left atrial appendage in humans. , 2011, Heart rhythm.

[110]  Saibal Kar,et al.  Safety of Percutaneous Left Atrial Appendage Closure: Results From the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry , 2011, Circulation.

[111]  A. Natale,et al.  Left Atrial Appendage Studied by Computed Tomography to Help Planning for Appendage Closure Device Placement , 2010, Journal of cardiovascular electrophysiology.

[112]  N. Cook,et al.  A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. , 2010, European heart journal.

[113]  N. Barış,et al.  The association of beta-fibrinogen 455 G/A gene polymorphism with left atrial thrombus and severe spontaneous echo contrast in atrial fibrillation. , 2010, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.

[114]  H. Alkadhi,et al.  Left atrial appendage clip occlusion: early clinical results. , 2010, The Journal of thoracic and cardiovascular surgery.

[115]  Maurice Buchbinder,et al.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2009, The Lancet.

[116]  Susan B. Johnson,et al.  Percutaneous Epicardial Left Atrial Appendage Closure: Preliminary Results of an Electrogram Guided Approach , 2009, Journal of cardiovascular electrophysiology.

[117]  P. Teirstein,et al.  Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. , 2009, JACC. Cardiovascular interventions.

[118]  A. Tuttolomondo,et al.  Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF). , 2009, Clinical science.

[119]  Timothy Watson,et al.  Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited , 2009, The Lancet.

[120]  E. Blackstone,et al.  Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. , 2008, Journal of the American College of Cardiology.

[121]  Douglas E. Lake,et al.  Analysis of in vivo left atrial appendage morphology in patients with atrial fibrillation: a direct comparison of transesophageal echocardiography, planar cardiac CT, and segmented three-dimensional cardiac CT , 2008, Journal of Interventional Cardiac Electrophysiology.

[122]  John D Ferguson,et al.  Cardiac cycle-dependent left atrial dynamics: implications for catheter ablation of atrial fibrillation. , 2008, Heart rhythm.

[123]  Randall J. Lee,et al.  Markers of inflammation before and after curative ablation of atrial flutter. , 2008, Heart rhythm.

[124]  G. Lip,et al.  Factor VII –323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk , 2008, Annals of medicine.

[125]  A. Arapaki,et al.  Warfarin versus aspirin for stroke prevention (BAFTA) , 2007, The Lancet.

[126]  S. Habara,et al.  Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. , 2007, European heart journal.

[127]  G. Lip,et al.  Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial , 2007, The Lancet.

[128]  E. Maltezos,et al.  Circulating levels of collagen type I degradation marker depend on the type of atrial fibrillation. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[129]  G. Lip,et al.  Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy. , 2007, Chest.

[130]  M. Borggrefe,et al.  A coronary embolus originating from the interatrial septum. , 2006, European heart journal.

[131]  M. Ezekowitz,et al.  Images in cardiovascular medicine. The case of a disappearing left atrial appendage thrombus: direct visualization of left atrial thrombus migration, captured by echocardiography, in a patient with atrial fibrillation, resulting in a stroke. , 2006, Circulation.

[132]  M. Pfeffer,et al.  Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial , 2006, The Lancet.

[133]  D. Packer,et al.  The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial. , 2006, American heart journal.

[134]  A. Iwasa,et al.  D-dimer level influences thromboembolic events in patients with atrial fibrillation. , 2006, International journal of cardiology.

[135]  G. Ekuklu,et al.  Hypercoagulopathy in Stroke Patients with Nonvalvular Atrial Fibrillation: Hematologic and Cardiologic Investigations , 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[136]  E. Lonn,et al.  Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. , 2005, American heart journal.

[137]  S. Pauker,et al.  Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[138]  G. Lip,et al.  Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. , 2004, American heart journal.

[139]  G. Lip,et al.  Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation. , 2004, Journal of molecular and cellular cardiology.

[140]  H. Sievert,et al.  Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. , 2004, Journal of the American College of Cardiology.

[141]  K. Kosmelj,et al.  High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy , 2003, Thrombosis and Haemostasis.

[142]  J. Bermejo,et al.  Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. , 2003, Journal of the American College of Cardiology.

[143]  G. Lip,et al.  Is Thrombogenesis in Atrial Fibrillation Related to Matrix Metalloproteinase-1 and Its Inhibitor, TIMP-1? , 2003, Stroke.

[144]  G. Lip,et al.  Atrial Fibrillation and the Prothrombotic State in the Elderly: The Rotterdam Study , 2003, Stroke.

[145]  A. Goette,et al.  Downregulation of Endocardial Nitric Oxide Synthase Expression and Nitric Oxide Production in Atrial Fibrillation: Potential Mechanisms for Atrial Thrombosis and Stroke , 2002, Circulation.

[146]  G. Lip,et al.  Is the Hypercoagulable State in Atrial Fibrillation Mediated by Vascular Endothelial Growth Factor? , 2002, Stroke.

[147]  Cynthia A. Carnes,et al.  C-Reactive Protein Elevation in Patients With Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation , 2001, Circulation.

[148]  K. Minematsu,et al.  Blood Flow in the Left Atrial Appendage and Embolic Stroke in Nonvalvular Atrial Fibrillation , 2001, European Neurology.

[149]  S. Mondillo,et al.  Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation. , 2000, International journal of cardiology.

[150]  I. Kronzon,et al.  Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study. , 2000, Journal of the American College of Cardiology.

[151]  G. Lip,et al.  von Willebrand factor, fibrinogen, and soluble P-selectin levels after mitral valve replacement versus mitral valve repair. , 2000, American Journal of Cardiology.

[152]  A. Goette,et al.  Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. , 2000, Journal of the American College of Cardiology.

[153]  J. Shirani,et al.  Structural remodeling of the left atrial appendage in patients with chronic non-valvular atrial fibrillation: Implications for thrombus formation, systemic embolism, and assessment by transesophageal echocardiography. , 2000, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[154]  C. Cierniewski,et al.  Dual regulatory effects of nitric oxide on plasminogen activator inhibitor type 1 expression in endothelial cells. , 2000, European journal of biochemistry.

[155]  A. Carter,et al.  Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation. , 1999, Circulation.

[156]  J. Redondo,et al.  Vascular Endothelial Growth Factor Activates Nuclear Factor of Activated T Cells in Human Endothelial Cells: a Role for Tissue Factor Gene Expression , 1999, Molecular and Cellular Biology.

[157]  U. Ikeda,et al.  Mitral regurgitation reduces the risk of stroke in patients with nonrheumatic atrial fibrillation. , 1998, American heart journal.

[158]  F. Neumann,et al.  Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[159]  B K Khandheria,et al.  Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. , 1997, Circulation.

[160]  M. Russo,et al.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.

[161]  J. Loscalzo,et al.  Nitric oxide released from activated platelets inhibits platelet recruitment. , 1997, The Journal of clinical investigation.

[162]  K. Berkin,et al.  Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. , 1997, Heart.

[163]  G. Lip,et al.  Thrombogenesis in Mitral Regurgitation and Aortic Stenosis , 1996, Angiology.

[164]  W. Manning,et al.  Antithrombotic therapy in atrial fibrillation. , 1996, Chest.

[165]  J. Odell,et al.  Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. , 1996, The Annals of thoracic surgery.

[166]  G. Lip.  Does atrial fibrillation confer a hypercoagulable state? , 1995, The Lancet.

[167]  G. Lip,et al.  Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. , 1995, British heart journal.

[168]  J. Coromilas,et al.  Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiographic study. , 1994, Journal of the American College of Cardiology.

[169]  Predictors of Thromboembolism in Atrial Fibrillation: II. Echocardiographic Features of Patients at Risk , 1992, Annals of Internal Medicine.

[170]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[171]  C. Pollick,et al.  Assessment of Left Atrial Appendage Function by Transesophageal Echocardiography: Implications for the Development of Thrombus , 1991, Circulation.

[172]  A. Weyman,et al.  Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. , 1990, Circulation.

[173]  A. Belanger,et al.  The Framingham study. , 1976, British medical journal.

[174]  J. Saw,et al.  VALVULAR AND STRUCTURAL HEART DISEASES Original Studies Device-Associated Thrombus Formation after Left Atrial Appendage Occlusion: A Systematic Review of Events Reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet , 2017 .

[175]  M. Price,et al.  Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device. , 2017, Heart rhythm.

[176]  J. Brachmann,et al.  Twelve-month follow-up of left atrial appendage occlusion with Amplatzer Amulet. , 2017, Cardiology journal.

[177]  S. Bolling,et al.  The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation. , 2017, The Annals of thoracic surgery.

[178]  J. Hiczkiewicz,et al.  First-in-human experience with the Cardia Ultraseal left atrial appendage closure device: The feasibility study. , 2016, Cardiology journal.

[179]  B. Meier,et al.  EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[180]  B. Meier,et al.  VALVULAR AND STRUCTURAL HEART DISEASES Original Studies Left Atrial Appendage Closure With Amplatzer Cardiac Plug in Atrial Fibrillation: Initial European Experience , 2011 .

[181]  R. Troughton,et al.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.

[182]  Xu-ping Li,et al.  The fibrosis and atrial fibrillation: is the transforming growth factor-beta 1 a candidate etiology of atrial fibrillation. , 2008, Medical hypotheses.

[183]  Y. Yoshida,et al.  Diagnosis of cardiac thrombosis in patients with atrial fibrillation in the absence of macroscopically visible thrombi , 2005, Virchows Archiv A.

[184]  D. Harrison,et al.  Downloaded from http://circres.ahajournals.org / by guest on February 23, 2013Shear Stress Regulates Endothelial Nitric Oxide Synthase Expression Through c-Src by Divergent Signaling Pathways , 2001 .

[185]  Transesophageal Echocardiographic Correlates of Thromboembolism in High-Risk Patients with Nonvalvular Atrial Fibrillation , 1998, Annals of Internal Medicine.

[186]  S. Burstein,et al.  Cytokines, platelet production and hemostasis. , 1997, Platelets.

[187]  Harry,et al.  C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. , 1993, Blood.

[188]  K. Cao,et al.  STRUCTURAL : ATRIAL INTERVENTION FOCUS Percutaneous Left Atrial Appendage Closure With the LAmbre Device for Stroke Prevention in Atrial Fibrillation A Prospective , Multicenter Clinical Study , 2022 .